期刊文献+

艾司西酞普兰治疗惊恐障碍对照研究 被引量:9

Study of escitalopram and sertraline in treatment of panic disorder
下载PDF
导出
摘要 目的:研究艾司西酞普兰和舍曲林治疗惊恐障碍的有效性和安全性。方法:65例惊恐障碍患者随机分入艾司西酞普兰组与舍曲林组治疗10周,在治疗前和治疗期间隔周测定惊恐症状评定量表(PASS)、临床总体印象-严重性(CGI-SI)、患者总体评价(PGE),汉密尔顿焦虑量表(HAMA)及每周发作次数,以治疗中出现的症状量表(TESS)评定不良反应。结果:艾司西酞普兰组有效率为96.8%,舍曲林组为93.3%,二药相近。两组患者在治疗10周PASS、CGI-SI、PGE、HAMA的减分率差异无显著性。艾司西酞普兰组的起效时间快于舍曲林组,差异具有显著性(P<0.01)。两组患者均有良好的耐受性。结论:艾司西酞普兰是一种起效快、疗效好、安全性高的治疗惊恐障碍的药物。 Objective:To evaluate the efficacy and safety of eseitalopram and sertraline in the treatment of patients with panic disorder. Method:Sixty-five patients with panic disorder were randomly assigned to escitalopram grnup or sertraline group for 10 weeks. The panic symptom scale(PASS) , clinic global impression-severity of illness( CGI-SI ) ,patients general evaluate(PGE) and Hamihon anxiety scale( HAMA ) were used to evaluate the efficacy,and the treatment emergent symptom scale(TESS) were used to evaluate the side effects. Results:After 10 weeks treatment,the mean scores of PASS, CGI-SI, PGE and HAMA reduced in both groups . The rates of efficacy of eseitalopram and sertraline were 96.77% and 93.33% respectively,and there were no statistically significant differences in the efficacy between two groups. But it took effect more quickly in eseilalopram group than in sertraline group( P 〈 0.0f ). Patients of both groups had good tolerance. Conclusion : Escitalupram is an effective and well-tolerated drug in the treatment of panic disorder,and takes effect quickly.
出处 《临床精神医学杂志》 2010年第2期97-99,共3页 Journal of Clinical Psychiatry
关键词 艾司西酞普兰 舍曲林 惊恐障碍 escitalopram sertraline panic disorder
  • 相关文献

参考文献8

  • 1Owens M J, Knight DL, Nemeroff CB. Second-generation SSRIs : human monoamine transporter binding profile of escitalopram and R- fluoxetine[J].Biol Psychiatry ,2001,50:345-350.
  • 2Sanchez C. R-citalopram attenuates anxiolvtic effects of escitalopram in a rat ultrasonic vocalization model[ J ]. Eur J Pharmcol, 2003.464 : 155-158.
  • 3Sanchez C, Bergqvist PB, Brennum LT, et al. Escitalopram, the S- ( + ) -enantiomer of citalopram,is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities [ J ]. Psychopharmacology ( Bed ), 2003,167:353-362.
  • 4Sanchez C, Gruca P, Bien E, el al. R-citalopram counteracts the effect of eseitalopram in a rat conditioned fear stress model of anxiety[ J ]. Pharmacol Bioehem Behay 2003,75:903-907.
  • 5Jonathan RT,Anjana B,Andrew K,et al. Escitalopram in the treatmeat of generalized anxiety disorder: double-blind, placebo-controlled,flexible-dose study [ J ]. Depression and anxiety 2004,19 : 234 -240.
  • 6Michael G,Riehard M, Philip C. Short oxford Textbook of Psychiatry[ M ]. 5th ed. New Yord : Oxford University Press,2006 : 193.
  • 7Dyckman JM, Rosenbaum RL, Hartmeyer RJ,et al. Effects of psychological intervention on panic attack patients in the emergency department[J].Psychosomatics 1999,40,422-427.
  • 8Hofmann S, Barlow DH. The costs of anxiety disorders. In: Miller NE, Magruder KM, eds. Cost-effectiveness of psychotherapy: A guide fi)r practitioners, researchers, and polieymakers [ M ]. New York :Oxford University Press, 1999:224-243.

同被引文献74

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部